Rubinstein, G.; Ilhan, H.; Bartenstein, P.; Lehner, S.; Hacker, M.; Todica, A.; Zacherl, M.J.; Fischer, M.
Peptide Receptor Radionuclide Therapy Using 90Y- and 177Lu-DOTATATE Modulating Atherosclerotic Plaque Inflammation: Longitudinal Monitoring by 68Ga-DOTATATE Positron Emissions Tomography/Computer Tomography. Diagnostics 2024, 14, 2486.
https://doi.org/10.3390/diagnostics14222486
AMA Style
Rubinstein G, Ilhan H, Bartenstein P, Lehner S, Hacker M, Todica A, Zacherl MJ, Fischer M.
Peptide Receptor Radionuclide Therapy Using 90Y- and 177Lu-DOTATATE Modulating Atherosclerotic Plaque Inflammation: Longitudinal Monitoring by 68Ga-DOTATATE Positron Emissions Tomography/Computer Tomography. Diagnostics. 2024; 14(22):2486.
https://doi.org/10.3390/diagnostics14222486
Chicago/Turabian Style
Rubinstein, German, Harun Ilhan, Peter Bartenstein, Sebastian Lehner, Marcus Hacker, Andrei Todica, Mathias Johannes Zacherl, and Maximilian Fischer.
2024. "Peptide Receptor Radionuclide Therapy Using 90Y- and 177Lu-DOTATATE Modulating Atherosclerotic Plaque Inflammation: Longitudinal Monitoring by 68Ga-DOTATATE Positron Emissions Tomography/Computer Tomography" Diagnostics 14, no. 22: 2486.
https://doi.org/10.3390/diagnostics14222486
APA Style
Rubinstein, G., Ilhan, H., Bartenstein, P., Lehner, S., Hacker, M., Todica, A., Zacherl, M. J., & Fischer, M.
(2024). Peptide Receptor Radionuclide Therapy Using 90Y- and 177Lu-DOTATATE Modulating Atherosclerotic Plaque Inflammation: Longitudinal Monitoring by 68Ga-DOTATATE Positron Emissions Tomography/Computer Tomography. Diagnostics, 14(22), 2486.
https://doi.org/10.3390/diagnostics14222486
